(AOF) – The board of directors of the American health insurer UnitedHealth has authorized a 14% increase in its quarterly cash dividend. A cash dividend of $1.88 per share will be paid on June 27, 2023 to all shareholders of record on June 19, 2023.
AOF – LEARN MORE
A strong development momentum for French life insurance
The growth of life insurance continues over the months. Over the first four months of the year, contributions reached 53.7 billion euros, a level not seen for more than ten years. At 10.5 billion euros, net inflows also returned to their highest level since 2011 over a similar period. In the end, at the end of April 2022, outstanding life insurance contracts reached 1.847 billion euros, up 1.1% over one year. These good performances are partly linked to the growing success of the PER (Retirement Savings Plan). Since the start of 2022, PERs marketed by an insurer have posted 592,000 additional policyholders and 9.3 billion euros in payments. At the end of April 2022, 3.2 million policyholders held a PER, which represented an outstanding amount of 39 billion euros. Without taking transfers into account, 87% of new holders of a PER (at the end of December 2021) had taken it out with an insurer.
Find out more about the “pharmacy” sector
Loss of speed in European research
European research is losing ground to American and Chinese research. In twenty years, Europe’s share has fallen from 41% to 31% in global R&D. China’s share jumped from 1% to 8%. As for the United States, which supplanted Europe, in 2001 it devoted only 2 billion euros per year more than Europe to R&D, whereas now this gap has reached 25 billion! Some experts accuse the European authorities of not having deployed effective policies. The financing of pharmaceutical research should therefore have been better targeted via the “Horizon 2020” programme. France only comes in eighteenth position in European funding despite the quality of its research. Conversely, the United States concentrates funding on Boston and a few centers of excellence.